Latest Breaking News On - Zusz - Page 12 : comparemela.com

3 Min Read ZURICH (Reuters) -Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid REGEN-COV, a combination of casirivimab and imdevimab, protected household contacts from exposure to SARS-CoV-2, with 72% protection against symptomatic infections in the first week, and 93% after that, according to trial data released by the company.

United statesCaroline copleyJohn millerHugh lawsonThomson reuters trust principlesUniversity of pennsylvaniaSouth san franciscoThomson reuters trustCorona virusBio therapeutic drugs trbc level 5Content produced in bangaloreCompany newsDrug amp device developmentHealth medicineBiotechnology amp medical research trbc level 4Pharmaceuticals nec trbc level 5